Landscapes / Companies
Sutro Biopharma, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 1
Drugs
2
in active trials · 4 in all
Trials
2 active
8 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1 | Dec 2027Phase 1 trial completes | |||
| Next date | Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Head and Neck Squamous Cell Carcinoma HNSCC, Non-Small Cell Lung Cancer NSCLC and 7 more | ||||
| Open drug page | |||||
— |
Phase 1 | Feb 2028Phase 1 trial completes | |||
| Next date | Feb 2028 · Phase 1 trial completes | ||||
| Also tested for | Head & Neck Squamous Cell Carcinoma, Non-Small Cell Lung Cancer and 6 more | ||||
| Open drug page | |||||
About
- No active trial
- Luveltamab tazevibulin, STRO-001
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021